文献速递神经肿瘤

成人小脑胶质母细胞瘤的复发模式与临床结局

Recurrence patterns and clinical outcomes in adult cerebellar glioblastoma.
PubMed 文献 · Acta Neurochir (Wien) · 2025-08-08

中位无进展生存期15.3个月,中位总生存期22.8个月;8例复发者中7例为远处或播散性复发,仅1例局部复发。所有肿瘤均无IDH1/2、H3F3A或TERT启动子突变。

要点

  • 小脑胶质母细胞瘤复发以远处或播散性为主,局部复发少见。
  • 所有病例均无IDH1/2、H3F3A或TERT启动子突变。
  • 中位无进展生存期15.3个月,中位总生存期22.8个月。

核心结论

  • 小脑胶质母细胞瘤的复发模式和遗传特征(IDH、H3F3A、TERT启动子区域)与典型幕上胶质瘤不同。

主要发现

  • 所有病例病理均显示微血管增生和/或坏死。
  • 中位无进展生存期为15.3个月,中位总生存期为22.8个月。
  • 8例复发患者中7例为远处或播散性复发,仅1例局部复发。
  • 所有肿瘤均无IDH1/2、H3F3A或TERT启动子突变;3例MGMT表达阴性,4例阳性。

临床怎么用

  • 小脑胶质母细胞瘤术后随访应关注远处或播散性复发,而非仅局部复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebellar glioblastoma in adults is a rare brain tumor with poor outcomes. This study aimed to assess the clinical characteristics, genetic features, and prognosis of a series of cerebellar glioblastomas, with special attention to their recurrence patterns. METHODS: We retrospectively analyzed patients who underwent treatment between 2008 and 2023. The patient characteristics, treatment methods, genetic features, and prognoses were assessed. RESULTS: Among 274 cases of histological glioblastomas, eleven patients with cerebellar glioblastomas were identified. Pathological results revealed microvascular proliferation and/or necrosis in all cases. All patients underwent surgery and local radiotherapy combined with temozolomide chemotherapy. The median progression-free survival and overall survival were 15.3 months and 22.8 months, respectively. Subventricular zone involvement was recognized in ten patients. Of the eight patients who experienced recurrence, seven had distant or disseminated recurrence, and only one experienced local recurrence. None of the tumors harbored mutations in the IDH1/2, H3F3A, or TERT promoters. Three patients showed negative expression of O6-methylguanine DNA methyltransferase (MGMT), and four patients showed positive expression. CONCLUSIONS: In our cohort, cerebellar glioblastomas showed clinical characteristics such as recurrence patterns and genetic features such as IDH, H3F3A, and TERT promoter regions that differed from those of typical supratentorial gliomas. Further studies are necessary to fully elucidate the clinical characteristics.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Oki S, Yamaguchi S, Ishi Y, et al. Recurrence patterns and clinical outcomes in adult cerebellar glioblastoma. Acta Neurochir (Wien). 2025. PMID: 40779131. doi:10.1007/s00701-025-06633-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。